FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Lincomed 300 Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Human Warnings: Not for human use. Keep out of reach of children.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
INDICATIONS FOR SWINE:
LincoMed® 300 is indicated for the treatment of infectious forms of arthritis caused by organisms sensitive to its activity. This includes most of the organisms responsible for the various infectious arthritides in swine, such as staphylococci, streptococci, Erysipelothrix and Mycoplasma spp.
It is also indicated for the treatment of mycoplasma pneumonia.
History
There is currently no drug history available for this drug.
Other Information
LincoMed® 300
lincomycin injection, USP
Swine Antibiotic
Restricted Drug (California) - Use only as Directed.
For Use in Animals Only
ANADA 200-368, Approved by FDA
Net Content: 100ml (3.3 fl oz)
For use in swine weighing 300 pounds or more.
For Intramuscular Use in Swine Only
DESCRIPTION:
LincoMed® 300 contains lincomycin hydrochloride, an antibiotic produced by Streptomyces lincolnensis var. lincolnensis which is chemically distinct from all other clinically available antibiotics and is isolated as a white crystalline solid.
Sources
Lincomed 300 Manufacturers
-
Bimeda Inc., Animal Health, Division Of Cross Vetpharm Group
Lincomed 300 | Bimeda Inc., Animal Health, Division Of Cross Vetpharm Group
DOSAGE AND ADMINISTRATION:
For arthritis or mycoplasma pneumonia - 5 mg/lb body weight intramuscularly once daily for three to seven days as needed. One mL per 60 lb body weight will provide 5 mg/lb.
For optimal results, initiate treatment as soon as possible. As with any multi-dose vial, practice aseptic techniques in withdrawing each dose. Adequately clean and disinfect the vial closure prior to entry with a sterile needle and syringe. No vial closure should be entered more that 20 times.
Each mL contains:
Lincomycin hydrochloride equivalent to lincomycin 300mg; also benzyl alcohol 9.45 mg added as a preservative.
Login To Your Free Account